Apoptosis, Caspase Activation Inhibitor (AVEN) (N-Term) Peptid
AVEN
Reaktivität: Human
BP
Sodium azide
Produktnummer ABIN1382087
-
-
Target
Alle AVEN Produkte
-
AVEN
(Apoptosis, Caspase Activation Inhibitor (AVEN))
-
Protein Region
-
N-Term
-
Spezies
-
Human
-
Applikation
-
Blocking Peptide (BP)
-
Produktmerkmale
-
14 amino acids near the amino terminus of human Aven.
Human
-
-
-
Applikationshinweise
-
Aven peptide is used for blocking activity of Aven.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Konzentration
-
200 μg/mL
-
Buffer
-
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
Konservierungsmittel
-
Sodium azide
-
Vorsichtsmaßnahmen
-
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
-20 °C
-
Haltbarkeit
-
12 months
-
-
Target
-
AVEN
(Apoptosis, Caspase Activation Inhibitor (AVEN))
-
Synonyme
-
AVEN Peptide, pdcd12 Peptide, aven Peptide, wu:fc08c09 Peptide, si:ch211-150c22.4 Peptide, PDCD12 Peptide, 1700013A01Rik Peptide, 1700056A21Rik Peptide, mAven-L Peptide, mAven-S Peptide, apoptosis and caspase activation inhibitor Peptide, apoptosis, caspase activation inhibitor L homeolog Peptide, apoptosis, caspase activation inhibitor Peptide, Aven Peptide, AVEN Peptide, aven.L Peptide, aven Peptide
-